Skip to main content

Table 1 Risk groups according to ESMO-ESGO-ESTRO Consensus Conference [3]

From: Endometrial cancer—how many patients could benefit from sentinel lymph node dissection?

  Grading Histological type Stage LVSI
Low risk G1, G2 Endometrioid IA Negative
Intermediate risk G1, G2 Endometrioid IA Positive
G1, G2 Endometrioid IB Negative
G3 Endometrioid IA Negative
High-intermediate risk G3 Endometrioid IA Positive
G1, G2 Endometrioid IB Positive
High risk G3 Endometrioid IB Negative/positive
G3 Non-endometrioid IA/B Negative/positive
   II Negative/positive
  1. Stages IA myometrial invasion < 50%, IB myometrial invasion ≥ 50%; stage II cervical involvement; LVSI lymphovascular space invasion